Key indicators: measuring the Alliance's progress against its four strategic goals

VACCINESCOUNTRY UPTAKEFRONTLOADINGMARKET-SHAPING

GAVI-funded vaccines have prevented more than 5m future deaths

In its first decade, GAVI has helped prevent more than five million future deaths through routine immunisation against hepatitis B, Haemophilus influenzae type b (Hib) and pertussis (whooping cough), and one-off investments in immunisation against measles, polio and yellow fever. Many more have been protected against debilitating illness and disability.

Source: These estimates and projections are produced by the WHO Department of Immunization, Vaccines and Biologicals, based on the most up to date data and models available as of November 2010

Immunisation coverage has climbed steadily in the last decade. Coverage for three doses of the diphtheria-tetanus-pertussis vaccine (DTP3) in low income countries in 2010 is projected at 79% - the highest level ever seen in the developing world. From 2000 to 2010, more than 288 million children have been immunised with GAVI-funded vaccines.

Source: Source: WHO-UNICEF coverage estimates for 1980-2009, as of July 2010; WHO ICE- T coverage projections for 2010-2011, as of September 2010; World Population Prospects, the 2008 revision. New York, United Nations, 2009; (surviving infants).